Yakoot M[au] - Search Results

Year	Number of Results
2008	1
2009	1
2010	2
2011	4
2012	3
2013	2
2014	1
2015	3
2016	1
2017	1
2018	3
2019	5
2020	2
2021	1
2022	2
2023	0

1

Nonsignificant trends in COVID-19 trials: Is there a significance?

Yakoot M. Yakoot M. J Med Virol. 2022 May;94(5):1757-1760. doi: 10.1002/jmv.27565. Epub 2022 Jan 11. J Med Virol. 2022. PMID: 34970753 Free PMC article.

2

A short review of the anthelmintic role of Mirazid.

Yakoot M. Yakoot M. Arq Gastroenterol. 2010 Oct-Dec;47(4):393-4. doi: 10.1590/s0004-28032010000400014. Arq Gastroenterol. 2010. PMID: 21225152 Free article. Review.

3

Addressing Diverse Petroleum Industry Problems Using Machine Learning Techniques: Literary Methodology-Spotlight on Predicting Well Integrity Failures.

Salem AM, Yakoot MS, Mahmoud O. Salem AM, et al. Among authors: yakoot ms. ACS Omega. 2022 Jan 7;7(3):2504-2519. doi: 10.1021/acsomega.1c05658. eCollection 2022 Jan 25. ACS Omega. 2022. PMID: 35097252 Free PMC article. Review.

4

Eosinophilic digestive disease (EDD) and allergic bronchial asthma; two diseases or expression of one disease in two systems?

Yakoot M. Yakoot M. Ital J Pediatr. 2011 Apr 16;37:18. doi: 10.1186/1824-7288-37-18. Ital J Pediatr. 2011. PMID: 21496295 Free PMC article. Review.

5

Phenylpropanolamine and the hemorrhagic stroke: A new search for the culprit.

Yakoot M. Yakoot M. J Pharmacol Pharmacother. 2012 Jan;3(1):4-6. doi: 10.4103/0976-500X.92491. J Pharmacol Pharmacother. 2012. PMID: 22368408 Free PMC article. No abstract available.

6

Follow-up of chronic paediatric hepatitis C virus in a low-/middle-income country.

El-Shabrawi M, Baroudy S, Hassanin F, Behairy AS, Yakoot M, Ahmed A. El-Shabrawi M, et al. Among authors: yakoot m. Acta Paediatr. 2020 Dec;109(12):2699-2705. doi: 10.1111/apa.15333. Epub 2020 May 20. Acta Paediatr. 2020. PMID: 32358871

7

Bridging the gap between alternative medicine and evidence-based medicine.

Yakoot M. Yakoot M. J Pharmacol Pharmacother. 2013 Apr;4(2):83-5. doi: 10.4103/0976-500X.110868. J Pharmacol Pharmacother. 2013. PMID: 23761704 Free PMC article. No abstract available.

8

Effectiveness of 8-week sofosbuvir/ledipasvir in the adolescent chronic hepatitis C-infected patients.

El-Khayat H, Kamal EM, Yakoot M, Gawad MA, Kamal N, El Shabrawi M, Sameh Y, Haseeb A, Fouad Y, Attia D. El-Khayat H, et al. Among authors: yakoot m. Eur J Gastroenterol Hepatol. 2019 Aug;31(8):1004-1009. doi: 10.1097/MEG.0000000000001360. Eur J Gastroenterol Hepatol. 2019. PMID: 30676473

9

Dual Sofosbuvir/Daclatasvir Therapy in Adolescent Patients With Chronic Hepatitis C Infection.

Yakoot M, El-Shabrawi MH, AbdElgawad MM, Mahfouz AA, Helmy S, Abdo AM, El-Khayat HR. Yakoot M, et al. J Pediatr Gastroenterol Nutr. 2018 Jul;67(1):86-89. doi: 10.1097/MPG.0000000000001968. J Pediatr Gastroenterol Nutr. 2018. PMID: 29570560

10

Effects of dual sofosbuvir/daclatasvir therapy on, chronic hepatitis C infected, survivors of childhood malignancy.

El-Shabrawi MH, Sherief LM, Yakoot M, Kamal NM, Almalky MA, AbdElgawad MM, Mahfouz AA, Helmy S, Kamal EM, Attia D, El-Khayat HR. El-Shabrawi MH, et al. Among authors: yakoot m. World J Clin Cases. 2019 Aug 26;7(16):2247-2255. doi: 10.12998/wjcc.v7.i16.2247. World J Clin Cases. 2019. PMID: 31531319 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results